NCT05272618

Brief Summary

To compare clinical outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA) according to the coronary microvascular dysfunction (CMD), evaluated by optical coherence tomography (OCT), invasive and non-invasive coronary physiologic assessment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
33mo left

Started Feb 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Feb 2022Dec 2028

Study Start

First participant enrolled

February 14, 2022

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

February 28, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 9, 2022

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

February 24, 2025

Status Verified

February 1, 2025

Enrollment Period

5.9 years

First QC Date

February 28, 2022

Last Update Submit

February 20, 2025

Conditions

Keywords

MINOCACoronary physiologyCardiac PETCFRIMROCT

Outcome Measures

Primary Outcomes (1)

  • MACCE

    a composite of cardiac death, any MI, any revascularization, stroke, readmission due to heart failure

    2-Year after enrollment

Secondary Outcomes (9)

  • cardiac death

    2-Year after enrollment

  • all-cause death

    2-Year after enrollment

  • Rate of myocardial infarction

    2-Year after enrollment

  • Rate of repeat revascularization

    2-Year after enrollment

  • Rate of stroke

    2-Year after enrollment

  • +4 more secondary outcomes

Study Arms (2)

MINOCA with CMD

MINOCA patients with CMD proven by invasive or non-invasive method

Diagnostic Test: Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET)

MINOCA without CMD

MINOCA patients without CMD

Diagnostic Test: Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET)

Interventions

Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET)

MINOCA with CMDMINOCA without CMD

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

About 150 patients with suspected myocardial infarction underwent invasive coronary angiography, but without obstructive coronary arteries will be enrolled. These patients will be evaluated by OCT, coronary functional assessment including coronary spasm test, invasive (FFR, CFR, IMR) and non-invasive coronary physiologic assessment (N-13 ammonia positron emission tomography).

You may qualify if:

  • Subject with age ≥19 years and acute myocardial infarction
  • Rise and/or fall of cardiac troponin with one level \>99 percentile plus ischemic signs/symptoms
  • Subject with non-obstructive coronary arteries
  • \<50% diameter stenosis or
  • fractional flow reserve (FFR) \>0.80 ③ Subject without previous history of coronary artery disease
  • Subject who performed invasive coronary angiography within 24 hours after presentation ⑤ Subject who eligible for invasive and non-invasive coronary physiologic assessment

You may not qualify if:

  • Subject with obstructive coronary arteries
  • Subject with alternate diagnosis including sepsis, pulmonary embolism, myocarditis, Takotsubo syndrome, spontaneous coronary dissection, and other cardiomyopathies.
  • Subject with cardiogenic shock or cardiac arrest ④ Subject who has non-cardiac co-morbid conditions with life expectancy \<1 year ⑤ Subject or lactating women ⑥ Subject unable to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chonnam National University Hospital

Gwangju, 61469, South Korea

RECRUITING

MeSH Terms

Conditions

Myocardial InfarctionCoronary VasospasmMINOCA

Interventions

Tomography, Optical Coherence

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisCoronary Disease

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Study Officials

  • Young Joon Hong, MD, PhD

    Chonnam National University Medical School; Chonnam National University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Young Joon Hong, MD, PhD

CONTACT

Seung Hun Lee, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 28, 2022

First Posted

March 9, 2022

Study Start

February 14, 2022

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

February 24, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

After the publication of the main paper, we have a plan to share IPD regarding the request.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
December 31, 2026 \~
Access Criteria
Not specified. To be discussed.

Locations